Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATRY study of perioperative tranexamic acid in gastric bypass surgery
2022-001384-27Phase 4Active
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in class III obesity (2 arms), sponsored by Franciscus Gasthuis & Vlietland. Primary endpoint: Reintervention rate for postoperative hemorrhage. Started Feb 2023; status: active.
02
Drugs
tranexamic acid
03
Conditions
class III obesity
Beyond the preview
Go deeper on 2022-001384-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001384-27.